ASC Therapeutics
生物技术
Milpitas,CA 2,016 位关注者
ASC Therapeutics develops biopharmaceuticals based on proprietary gene, CRISPR and allogeneic cell therapies
关于我们
ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities. #therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia www.asctherapeutics.com
- 网站
-
https://www.asctherapeutics.com
ASC Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Milpitas,CA
- 类型
- 私人持股
- 创立
- 2008
- 领域
- Clinical、Biologics、AAV、Cell Therapy、Gene Therapy、Biotech、Therapeutic、Genome Editing、Blood disease、Genetic disease、CRISPR、Phase I study、Gene Replacement、Stem Cells、Biotech Venture、Start up、Phase II和Drug development
地点
-
主要
521 Cottonwood Drive Suite 111
US,CA,Milpitas,95035